Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Paula Bendet
Journal Article
Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics Open Access
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 2, February 2020, Pages 392–399, https://doi.org/10.1093/jac/dkz460
Published: 12 November 2019
Journal Article
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 7, July 2019, Pages 1952–1961, https://doi.org/10.1093/jac/dkz143
Published: 30 April 2019
Journal Article
EDITOR'S CHOICE
Once-a-week tigecycline for the treatment of drug-resistant TB Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 6, June 2019, Pages 1607–1617, https://doi.org/10.1093/jac/dkz061
Published: 28 February 2019
Journal Article
Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis Free
Clinical Infectious Diseases, Volume 67, Issue suppl_3, 15 December 2018, Pages S274–S283, https://doi.org/10.1093/cid/ciy618
Published: 28 November 2018
Journal Article
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis Free
Clinical Infectious Diseases, Volume 67, Issue suppl_3, 15 December 2018, Pages S293–S302, https://doi.org/10.1093/cid/ciy611
Published: 28 November 2018
Journal Article
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis Free
Clinical Infectious Diseases, Volume 67, Issue suppl_3, 15 December 2018, Pages S317–S326, https://doi.org/10.1093/cid/ciy609
Published: 28 November 2018
